MORPHINE SULPHATE 15MG/ML INJECTION

Valsts: Kipra

Valoda: grieķu

Klimata pārmaiņas: Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

Aktīvā sastāvdaļa:

MORPHINE SULFATE

Pieejams no:

MARTINDALE PHARMACEUTICALS LTD (0000003314) BAMPTON ROAD, HAROLD HILL, ROMFORD, RM3 8UG

ATĶ kods:

N02AA01

SNN (starptautisko nepatentēto nosaukumu):

MORPHINE

Deva:

15MG/ML

Zāļu forma:

INJECTION

Kompozīcija:

MORPHINE SULFATE (0000064313) 15MG

Ievadīšanas:

INTRAMUSCULAR USE; INTRAVENOUS USE; ΥΠΟΔΟΡΙΑ ΧΡΗΣΗ

Receptes veids:

Εθνική Διαδικασία

Ārstniecības joma:

MORPHINE

Produktu pārskats:

Νομικό καθεστώς: Με Ιατρική Συνταγή σύμφωνα με την Περί Ναρκωτικών Φαρμάκων και Ψυχοτρόπων Ουσιών Νομοθεσία; 10 AMP X 1ML (200045701) 10 AMPOULE - Εγκεκριμένο - Με Ιατρική Συνταγή σύμφωνα με την Περί Ναρκωτικών Φαρμάκων και Ψυχοτρόπων Ουσιών Νομοθεσία

Lietošanas instrukcija

PACKAGE LEAFLET: INFORMATION FOR THE USER
Morphine Sulfate Injecton BP 10mg/ml, 15mg/ml, 20mg/ml & 30mg/ml
Morphine Sulfate
READ THIS LEAFET CAREFULLY BEEFRRE YRU ARE GIVEN THIS MEDICINE(

Keep this leafet you may need to read it again

If you have any further questons, please ask your doctor or nurse.

If any of the side efects gets serious, or if you notce any side
efects not listed in this leafet
please tell your doctor or nurse.
IN THIS LEAFET:
1.
What Morphine Sulfate Injecton is and what it is used for
2.
Before you are given Morphine Sulfate Injecton
3.
How Morphine Sulfate Injecton will be given
4.
Possible side efects
5.
How to store Morphine Sulfate Injecton
6.
Further informaton
1(
WHAT MRRPHINE SULFATE INJECTRN IS AND WHAT IT IS USED FRR
Morphine is an alkaloid with powerful pain relieving propertes.
This medicine is used for the relief of severe pain.
2(
BEFRRE YRU ARE GIVEN MRRPHINE SULFATE INJECTRN
You should not be given Morphine Sulfate Injecton iff

you are allergic (hypersensitvee to Morphine or any of the ingredients
listed in secton 6 of
this leafet

you are currently taking drugs used to treat depression known as
monoamine oxidase
inhibitors (MAOIse or have taken them in the last 2 weeks

you sufer from breathing difcultes (asthma or chronic obstructve
airways diseasee

you have sufered a head injury

you sufer from alcoholism

you sufer from heart problems

you are sufering from stomach pains

you are sufering from a tumour of the adrenal gland known as
phaeochromocytoma

you are pregnant or breast-feeding

your child has a liver or kidney problem.
TAKE SPECIAL CARE WITH MRRPHINE SULFATE INJECTRN IF:

you sufer from low blood pressure

you sufer from underactve thyroid

you sufer from problems with your prostate gland

you sufer from any liver or kidney diseases

you sufer from fts
TAKING RTHER MEDICINES
Please tell your doctor or nurse if you are taking, or have recently
taken, any other medicine
including medicines obtained without pre

Produkta apraksts

PRODUCT SUMMARY
1.
NAME OF THE MEDICINAL PRODUCT
Morphine Sulfate Injection BP 15mg in 1ml
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Morphine Sulfate BP 1.5 % w/v
3.
PHARMACEUTICAL FORM
Solution for Injection
4.
CLINICAL PARTICULARS
4.1.
THERAPEUTIC INDICATIONS
For the relief of severe pain.
4.2.
POSOLOGY AND METHOD OF ADMINISTRATION
By intramuscular, subcutaneous or intravenous
injection. Adults
Initially 10 - 20mg, the dose may be repeated every 4-6 hours.
In cases of terminal pain higher doses may be required.
The
Elderly
Caution is advised. A reduction of dose is advisable.
Children
Not recommended at this strength.
4.3
CONTRA-INDICATIONS

Hypersensitivity to any of the products ingredients.

Acute respiratory depression or Chronic Obstructive Airways Disease.

Asthma attack.

Acute alcoholism.

Bilary colic.

Head injuries or increased intracranial pressure.

Heart failure secondary to lung disease.

Monoamine oxidase inhibitors (including moclobemide), or within two
weeks of their
withdrawal.

Risk of paralytic ileus.

Phaeochromocytoma.
4.4.
SPECIAL WARNINGS AND SPECIAL PRECAUTIONS FOR USE
Repeated use can cause tolerance and dependence. Caution in use should
be
excercised and a reduction in dose may be advisable in the elderly and
in the
following cases:

Hypotension.

Hypothyroidism.

Depressed respiratory reserve.

Prostatic hypertrophy.

Hepatic or renal impairment. ( Avoid or reduce dose).

Convulsive disorders.
4.5.
INTERACTIONS WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF
INTERACTION
Alcohol : Enhanced sedative and hypertensive effects.
Antidepressants: The use of morphine should be avoided or used with
caution in
patients receiving monoamine oxidase inhibitors (including
moclobemide), or within
two weeks of their withdrawal.
Anxiolytics, Hypnotics
and other CNS Depressants
: Sedative effects may be
enhanced by simultaneous use of morphine.
Ciprofloxacin:
Morphine
Sulfate
should not
be
used
as a
premedication when
ciprofloxacin is
used for surgic